Gland Pharma Limited has informed the Exchange regarding a press release dated December 03, 2024, titled "Gland Pharma receives approval for Latanoprost Ophthalmic Solution".
Gland Pharma Limited has informed the Exchange regarding a press release dated December 03, 2024, titled "Gland Pharma receives approval for Latanoprost Ophthalmic Solution".